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Supporting Information 
 
A. % Neutralization and the Probability Envelope Protein is Bound 
 
In this section, we determine the relationship between the experimentally measured % 
neutralization assay and the probability 𝑝bound (denoted by 𝑝1 + 𝑝2 in the main text) that an Env 
trimer spike will have an antibody bound to any of its three identical CD4 binding sites.  
 
We begin by defining how % neutralization is measured experimentally. We then analyze a 
linear model of HIV-1 infectivity discussed in the main text where the ability of HIV-1 to infect a 
target cell is proportional to the number of Env spikes not bound by antibodies. We also discuss 
alternate models of infectivity where some minimal number of active spikes are required for a 
virion to infect a cell and find that this model yields nearly identical predictions to the linear 
model. 
 
Lastly, we investigate the importance of the experimentally measured distribution of Env spikes 
on HIV. We begin with a simple model where each virion has the mean number of spikes 
dictated by this distribution. We then characterize the assumptions under which the resulting 
infectivity of the virus will not change if the number of spikes per virion is drawn from the full 
distribution. 
 
Defining % Neutralization 
Pseudovirus preparations are titered to determine the tissue culture infectious dose (TCID50). In 
vitro neutralization assays were done in 96 well plates, each well containing 250 TCID50 and 
25,000 cells that emit bioluminescence upon infection by the pseudovirus as described (40). 
Antibodies and other potential inhibitors of neutralization are in vast excess over pseudovirus 
and cells in these assays (e.g., 1 nM antibody corresponds to 1011 molecules/well). Upon 
infection, the cells emit light via a luciferase reporter as shown in Fig. S1A. We define the 
percent of pseudovirus neutralized as the fold-change in bioluminescence in the presence and 
absence of an inhibitor, namely, 
 
% neutralization = 100
(viral control − cell control) − (bioluminescence − cell control)
viral control − cell control
, [S1] 
where bioluminescence is a measure of the light emitted in a well containing the pseudoviruses, 
cells, and antibodies; viral control is an assay using only cells and viruses (no antibodies) so 
that the cells emit maximal bioluminescence; and cell control is an assay using only cells (no 
viruses or antibodies) (Fig. S1A). 
 
The relative infectivity of a virion is defined as 100 − (% neutralization), which equals 100% 
when no antibodies are present and 0% at saturating antibody concentrations where the binding 
sites on each HIV-1 spike are occupied by an inhibitor. 
 
A Linear Model of HIV-1 Infectivity 
We now consider the linear model for HIV-1 infectivity used in the main text, which is predicated 
on the following assumptions: (i) each virus has the same number 𝑁 = 14 of Env trimers (or 
spikes), taken to be the mean of the experimentally measured distribution, (ii) each spike is 
active (able to help HIV-1 infect a target cell) if none of its three Fab binding sites are occupied 
by an antibody and inactive otherwise, and (iii) the relative infectivity of a virion is linearly 
proportional to its number of active spikes. Taken together, these assumptions imply that a virus 
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with seven active Env trimers shown on the left in Fig. S1B will be half as infective as a 
completely unbound virus with 14 active trimers shown on the right. 
 
The first assumption simplifies our analysis; below we relax this assumption and show that it 
does not alter the % neutralization curves. The second assumption, that a spike is inactivated if 
at least one of its Fab sites is bound, is supported by experimental and computational studies 
(23). The third assumption has been observed when less than half the HIV-1 spikes are bound 
(27), but relative infectivity decreases faster than a linear model when more than half of the 
spikes are bound. In the following section, we relax this assumption and show that it may leads 
to slightly sharper % neutralization curves that agree less well with the data. 
 
Assuming the assumptions outlined above, a virion with 𝑛 active spikes out of 𝑁 = 14 spikes 
total will have 
𝑛
𝑁
 the relative infectivity of a completely unbound virus, and hence the % 
neutralization is given by the expectation 100 〈1 −
𝑛
𝑁
〉 which equals 0% in the absence of 
antibodies when all spikes are active (𝑛 = 𝑁) and equals 100% at saturating antibody 
concentrations when all spikes are inactive (𝑛 = 0). Given the probability 𝑝bound that any spike 
will be bound, the probability of having 𝑛 active (unbound) spikes equals (𝑁𝑛)(1 − 𝑝bound)
𝑛𝑝bound
𝑁−𝑛  
and hence % neutralization is given by  
 
% neutralization = 100 ∑ (
𝑁
𝑛
) (1 − 𝑝bound)
𝑛𝑝bound
𝑁−𝑛 (1 −
𝑛
𝑁
)
𝑁
𝑛=0
= 100 − 100 ∑ (
𝑁
𝑛
) (1 − 𝑝bound)
𝑛𝑝bound
𝑁−𝑛 𝑛
𝑁
𝑁
𝑛=0
= 100 − 100(1 − 𝑝bound) ∑ (
𝑁 − 1
𝑚
) (1 − 𝑝bound)
𝑚𝑝bound
𝑁−1−𝑚
𝑁−1
𝑚=0
= 100 𝑝bound, [S2]
 
 
where in the third equality we changed variables to 𝑚 = 𝑛 − 1. Therefore, we see that the 
formula Eq. 9 in the main text quantifying the probability that any of the Fab epitopes on an HIV-
1 trimer will be bound allows us to characterize the neutralization data in Fig. 2D. 
 
30 
 
 
 
Figure S1. A Linear model of HIV-1 neutralization. (A) Neutralization of HIV-1 pseudovirus 
was assayed by evaluating reporter cells that emit light upon HIV-1 infection via luciferase (1). 
Adding an inhibitor (e.g., a diFab) results in decreased bioluminescence. (B) We model each 
HIV-1 virion as having 14 spikes that are inactivated (represented as partially transparent 
spikes) when a 3BNC60 Fab is bound to any of its three binding sites on an Env trimer. In the 
main text, we assume a linear model in which the infectivity of a virion is proportional to its 
number of active spikes; for example, the virus on the right will be twice as infective as the virus 
on the left. (C) Different models for % neutralization (or the relative infectivity given by 
100 − % neutralization) as a function of the number of active (unbound) HIV-1 spikes (left) and 
their corresponding % neutralization curves (right). The geometric factor ?̃? in Eq. 8 quantifying 
the effects of diFab avidity was adjusted for each model (5 × 105 for the linear model; 3 × 105 
for the linear model with a hard threshold; 20 × 105 for the hard threshold model) to match the 
data. The values of the remaining parameters were the same as in Fig. 2. 
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Imposing a Hard Threshold for HIV-1 Infectivity 
We now relax the third assumption stated above that relative infectivity is proportional to the 
number of active (i.e., unbound) HIV-1 spikes (Fig. S1C, Linear). Instead, we posit that some 
minimum number of spikes must be active for a virion to be able to infect a target cell. This 
minimum number has been predicted to be between 1-3 active spikes (49). Hence, we 
investigate two additional models where at least 3 of the HIV-1 spikes must be active for a virion 
to infect a target cell. In the first model (Fig. S1C, Linear with a Hard Threshold), the relative 
infectivity increases linearly (and hence the % neutralization decreases linearly) with the number 
of active spikes >3, while in the second model (Fig. S1C, Hard Threshold) we impose a pure 
threshold so that a virus is maximally infective provided at least 3 spikes are active.  
 
For each model, we can alter the avidity factor ?̃? to best match the data (?̃? = 5 × 105, 3 × 105, 
or 20 × 105 for the linear model, the linear model with a hard threshold, or the hard threshold 
model, respectively), as shown in Fig. S1C for the (d=62, s=12) diFab. As expected, the linear 
model with a hard threshold is nearly identical to the linear model without this threshold, except 
that its % neutralization rises to 100% at lower antibody concentrations because it only needs to 
neutralize 𝑁 − 2 spikes to disable each virion. The hard-threshold model is sharper than the 
linear model, with the transition between no neutralization and full neutralization occurring when 
there are enough antibodies to bind 𝑁 − 2 spikes. While we note that data from in vitro 
neutralization assays are inherently noisy, the shallower linear response characterizes the data 
slightly better. Lastly we note that the neutralization profiles of other diFabs would have the 
same shape as the (d=62, s=12) curve and that the spacing between the other diFab 
neutralization curves is unchanged by the relationship between % neutralization and the number 
of active spikes. Therefore, using any of these models would minimally affect our results.  
 
% Neutralization is Unchanged if the Number of Env Spikes Varies between Virions 
In this section, we relax the first assumption stated above and consider the number of spikes 𝑁 
on each virion to be drawn from a distribution ranging from 7-30 spikes per virion with an 
average of 14 (22-26). We assume that the relative infectivity of a virus increases with each 
additional spike (with a maximum value attained by a virus with 𝑁max = 30 active spikes). The 
calculation for % neutralization follows analogously to Eq. S2, except that the % neutralization of 
a virus with 𝑛 active spikes is proportional to 1 −
𝑛
𝑁max
 and that % neutralization must be 
averaged over all possible values of 𝑁 drawn from its distribution, namely, 
% neutralization ∝ 〈∑ (
𝑁
𝑛
) (1 − 𝑝bound)
𝑛𝑝bound
𝑁−𝑛 (1 −
𝑛
𝑁max
)
𝑁
𝑛=0
〉
= 1 −
〈𝑁〉
𝑁max
(1 − 𝑝bound). [S3]
 
However, this function does not run from 0% to 100% (as does % neutralization), and upon 
stretching this function to span these two limits we recover the result that % neutralization =
100𝑝bound as in Eq. S2. 
 
This result is noteworthy in that it is independent of any details of the distribution (even the 
mean gets cancelled when the function is stretched to run from 0% to 100%). However, it rests 
upon the underlying assumption that relative infectivity increases linearly with the number of 
active spikes with no upper bound. If the relative infectivity saturates past a certain point (e.g., 
following a sigmoidal dependence), the result would no longer hold. However, given that HIV-1 
has so few spikes, it may turn out that each spike increases the relative infectivity of the virus by 
the same comparable amount.  
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B. Number of Microstates in a Model Excluding ssDNA 
 
In this section, we count the number of microstates available for bivalent binding in the simple 
model in which contributions from the ssDNA segments are ignored within the linker (Fig. 2A). 
The flexibility of the Fabs between the CH1-CL and VH-VL domains allows it to bend by a 
distance 𝑙flex. To simplify the calculation, we will only consider the motion of 𝑙flex in the direction 
colinear with the dsDNA strand so that the problem becomes one dimensional, with the relevant 
lengths shown in Fig. S2A. We define 𝑛(𝑙dsDNA) as the length along which the dsDNA can 
translate while the diFab is bivalently bound. Analyzing the system using a 1D lattice model 
where Δ𝑙 is the discretized length scale, the number of microstates for the bivalently bound 
configuration will be 
𝑛(𝑙dsDNA)
Δ𝑙
. 
 
When the dsDNA is too long (𝑙dsDNA ≥ 𝑙linker + 𝑙flex) or too short (𝑙dsDNA ≤ 𝑙linker − 𝑙flex), the 
diFab cannot bivalently bind and hence there are zero microstates (𝑛(𝑙dsDNA) = 0) in these 
limits. In between these two limits, bivalent binding is possible. 
 
Fig. S2B shows the case when the dsDNA is longer than the linker length (𝑙dsDNA ≥ 𝑙linker). 
When bivalently bound, the left-most position of the dsDNA occurs when the left Fab is flexing 
to its left-most position; the right-most position of the dsDNA similarly occurs when the right Fab 
is flexing to its right-most position. Therefore, the bivalently bound state will allow the dsDNA to 
translate by a distance 𝑛(𝑙dsDNA) = 𝑙flex − (𝑙dsDNA − 𝑙linker).  
 
Fig. S2C shows the corresponding case when the dsDNA is shorter than the linker (𝑙dsDNA ≤
𝑙linker). In this case, the left-most position of the dsDNA is dictated by the right Fab stretching to 
its left-most position, with a similar statement holding for the right-most DNA position. Hence, 
the dsDNA can slide by however much longer it is than the minimum distance 𝑙linker − 𝑙flex that 
allows bivalent binding, namely, 𝑙dsDNA − (𝑙linker − 𝑙flex). Putting the two cases together, the 
general expression or the length that the dsDNA can translate within the bivalent binding 
configurations is given by 
𝑛(𝑙dsDNA) = max(𝑙flex − |𝑙dsDNA − 𝑙linker|, 0) , [S4] 
leading to the number of microstates in Eq. 3, Ω2 =
𝑛(𝑙dsDNA)
Δ𝑙
. 
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Figure S2. Number of bivalent microstates in the model excluding ssDNA. (A) dsDNA of 
length 𝑙dsDNA must bridge the distance 𝑙linker between the C-termini of two bound Fabs. The 
CH1-CL and VH-VL hinge between the two Fabs is flexible, permitting the C-terminal CH1 domain 
residue to which the DNA is attached to flex about its central point by a distance 𝑙flex. (B) When 
the dsDNA is longer than the linker length, the left Fab can flex to its left-most point and the 
dsDNA can translate to the right until the right-most Fab reaches its right-most point. The length 
of the translation permitted when a diFab is bivalently bound is denoted by 𝑛(𝑙dsDNA). (C) When 
the dsDNA is shorter than the linker length, the left-most position of the dsDNA is dictated by 
the right Fab stretching to its left-most point; the dsDNA can translate to the right until the left 
Fab flexes to its right-most point. 
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C. Number of Microstates in the Model Including ssDNA 
 
In this section, we enumerate the number of microstates associated with the three states of an 
HIV-1 Env spike – the unbound state (Ω0), the singly bound state (Ω1), and the bivalently bound 
state (Ω2) – shown in Fig. S3A for the model where we include both the dsDNA and the ssDNA 
in the diFab linker.  
 
 
 
Figure S3. Conformational states of a diFab. (A) To bivalently bind, the linker region of a 
diFab (a length 𝑙dsDNA of dsDNA flanked by two lengths 𝑙ssDNA of ssDNA) must span a distance 
𝑙linker that is dictated by the Env protein’s structure. The dsDNA is a rigid rod while the ssDNA 
(shown floppy in Panel A) is modeled as an ideal chain (shown as straight line segments in 
Panel B). (B) The optimal tether will match 𝑙dsDNA ≈ 𝑙linker, because when 𝑙dsDNA ≪ 𝑙linker or 
𝑙dsDNA ≫ 𝑙linker the ssDNA must be extended, severely limiting the number of conformational 
states available and inducing a much larger entropic penalty cost for bivalent binding.  
 
The Ideal Chain Model for ssDNA and dsDNA 
We model the dsDNA as a 1D rigid rod and the ssDNA as a random walk with a step size given 
by its Kuhn length 𝑏ssDNA = 2𝜉ssDNA. While the Kuhn length of free ssDNA is 𝑏ssDNA = 3 nm =
4.7 bases (43, 44), we will determine the Kuhn length in our system through nonlinear fitting. As 
in the main text, 𝑙dsDNA and 𝑙ssDNA denote the lengths of the dsDNA and ssDNA, respectively. 
 
Intuitively, because random walks tend to wander around their starting point, the optimal diFab 
will match its dsDNA length to the distance between the C terminals of two bound Fabs 
(𝑙dsDNA ≈ 𝑙linker) to lose as little entropy as possibly when transitioning from a monovalently-
bound to a bivalently-bound state. As shown in Fig. S3B, a diFab that is too short (𝑙dsDNA ≪
𝑙linker) or too long (𝑙dsDNA ≫ 𝑙linker) must stretch its ssDNA outwards or inwards to bivalently 
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bind, thereby severely limiting the number of possible configurations in the doubly bound state. 
In the extreme limits where 𝑙linker > 𝑙dsDNA + 2𝑙ssDNA or 𝑙linker < 𝑙dsDNA − 2𝑙ssDNA, bivalent 
binding is impossible. We will now make these statements precise by computing the probability 
that a linker configuration will permit a diFab to be bivalently bound.  
 
Computing the Probability of Bivalent Binding 
We first turn our attention to the number of microstates of a bivalently bound linker ignoring the 
flexibility of the Fab shown in Fig. 2 (i.e., in the 𝑙flex = 0 limit). Our goal will be to compute the 
probability 𝑝(𝑙dsDNA, 𝑙ssDNA, 𝑙linker) that the two ssDNA random walks and the dsDNA segment 
will span the appropriate distance 𝑙linker necessary for the two Fabs to bivalently bind and then 
use this probability to count the number of microstates available for bivalent binding. In the last 
section of this Appendix, we consider the case of 𝑙flex ≠ 0. 
 
As shown in Fig. S4A, each ssDNA random walk is composed of 𝑛 =
𝑙ssDNA
𝑏ssDNA
 segments with Kuhn 
length 𝑏ssDNA = 2𝜉ssDNA given by twice the persistence length. The ssDNA and dsDNA in the 
linker must together span a fixed 𝑙linker, where the direction and magnitude of this vector is 
determined by the geometry of the Env spike’s epitopes. We now compute the probability that 
two ssDNA random walks sandwiched between a dsDNA rigid rod of size 𝑙dsDNA spans 𝑙linker. 
We proceed by considering four increasingly complex cases. 
 
Case 1: 𝑙dsDNA = 0⃗ , 𝑙linker = 0⃗  
We begin by analyzing the special case of a diFab with an infinitesimally small dsDNA segment 
(𝑙dsDNA = 0⃗ ) binding to two epitopes that essentially lie on top of one another (𝑙linker = 0⃗ ). In 
other words, the constraint 𝑙dsDNA = 0⃗  implies that both ssDNA random walks start off at the 
same location whereas 𝑙linker = 0⃗  specifies that both random walks must end at the same 
location. This setup is shown in Fig. S4B where the two random walks begin in the green square 
and end up within a small distance of each other represented by the gray cube. 
 
Rather than analyzing the first random walk (with steps 𝑠 1(1), 𝑠 1(2), and 𝑠 1(3)) and the second 
random walk (with steps 𝑠 2(1), 𝑠 2(2), and 𝑠 2(3)) individually, we construct an effective random 
walk that traverses along one of the original walks and back along the other (𝑠 eff(𝑗) = 𝑠 1(𝑗) for 
1 ≤ 𝑗 ≤ 3 and 𝑠 eff(𝑗) = −𝑠 2(𝑗 − 3) for 4 ≤ 𝑗 ≤ 6). This mapping is bijective, which means that 
every instance of the original random walks will correspond to a unique effective random walk 
and vice versa. This implies that the two original random walks will end at the same point if and 
only if the effective random walk ends near the origin. Therefore, 𝑝(0, 𝑙ssDNA, 0) equals the 
probability that this effective random walk returns to the origin. 
 
To make this argument precise, consider a 3D random walk starting at the origin and taking 𝑛 
steps of length 𝑏ss. The probability that a random walk will end inside an infinitesimal volume 𝑑𝑉 
centered at 𝑟  is given by (77) 
𝑃(𝑟 )𝑑𝑉 = 𝑑𝑉 (
3
2 𝜋 𝑛 𝑏ssDNA
2 )
3
2
𝑒
− 
3 𝑟2
2 𝑛 𝑏ssDNA
2
. [S5] 
Since each segment of the random walk can point in any direction, this probability only depends 
on the magnitude of 𝑟  and decreases exponentially with its distance from the origin. Note that 
𝑃(𝑟 ) is a probability density that upon multiplication by an infinitesimal volume 𝑑𝑉 denotes the 
probability of a random walk ending between 𝑟  and 𝑟 + 𝑑𝑟 . 
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Figure S4. The ideal chain model for a diFab linker. (A) We compute the probability 
𝑝(𝑙dsDNA, 𝑙ssDNA, 𝑙linker)  that the ssDNA (𝑛  segments of length 𝑏ssDNA ) and dsDNA (1 rigid 
segment of length 𝑙dsDNA) in the diFab linker will end at the appropriate distance 𝑙linker required 
for bivalent binding. We consider the following cases: (B) 𝑙dsDNA = 0⃗ , 𝑙linker = 0⃗ ; (C) 𝑙dsDNA =
0⃗ , 𝑙linker ≠ 0⃗ ; (D) 𝑙dsDNA ≠ 0⃗ , 𝑙linker = 0⃗ ; and the full model (E) 𝑙dsDNA ≠ 0⃗ , 𝑙linker ≠ 0⃗ . The two 
random walks start at each end of 𝑙linker, which is denoted by a green square when 𝑙linker = 0⃗  
(Panels B and D). Random walks end in the same location if they are within a small volume 𝑑𝑉 
of each other (Panels B and C) or if their ends are within 𝑑𝑉 of the dsDNA of length 𝑙dsDNA 
(Panels D and E). In each case, the two ssDNA random walks are combined into a single 
effective random walk with 2𝑛 steps. 
 
The probability that the effective random walk, formed by combining the two ssDNA random 
walks, will end up inside an infinitesimal volume 𝑑𝑉 from the origin is given by Eq. S5 with 𝑛 →
2𝑛 and 𝑟 → 0⃗ . Therefore, the fraction of bivalent binding configurations relative to monovalent 
binding configurations for two ssDNA random walks that start and end at the same location 
(𝑙dsDNA = 0⃗ , 𝑙linker = 0⃗ ) is given by 
𝑝(0, 𝑙ssDNA, 0) = 𝑃(0⃗ )𝑑𝑉 = 𝑑𝑉 (
3
4 𝜋 𝑛 𝑏ssDNA
2 )
3
2
. [S6] 
Defining Ω̅ to be the number of microstates of each independent ssDNA segment (the 2𝑛 
ssDNA segments are all assumed to rotate freely in the ideal chain model), the total number of 
microstates for the bivalent binding configurations is given by Ω̅2𝑛𝑝(0, 𝑙ssDNA, 0). 
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Case 2: 𝑙dsDNA = 0⃗ , 𝑙linker ≠ 0⃗  
We next consider the case where two ssDNA random chains with no interspersed dsDNA 
(𝑙dsDNA = 0) must end up at a displacement 𝑙linker. As shown in Fig. S4C, the two ssDNA 
random walks are equivalent to the probability that a single random walk with 2𝑛 steps will finish 
at 𝑙linker. Therefore, the fraction of random walk configurations that allow bivalent binding when 
𝑙dsDNA = 0⃗  and 𝑙linker ≠ 0⃗  is given by Eq. S5 with 𝑛 → 2𝑛 and 𝑟 → 𝑙linker, namely, 
𝑝(0, 𝑙ssDNA, 𝑙linker) = 𝑃(𝑙linker)𝑑𝑉 = 𝑑𝑉 (
3
4 𝜋 𝑛 𝑏ssDNA
2 )
3
2
𝑒
− 
3 𝑙linker
2
4 𝑛 𝑏ssDNA
2
. [S7] 
As in case 1, the total number of bivalent microstates is then given by Ω̅2𝑛𝑝(0, 𝑙ssDNA, 𝑙linker). 
 
Case 3: 𝑙dsDNA ≠ 0⃗ , 𝑙linker = 0⃗  
We next turn to a diFab whose two ssDNA ends must end at the same point (𝑙linker = 0) but 
whose linker contains dsDNA (𝑙dsDNA ≠ 0⃗ ) that can point in any direction. Analogous to the 
ssDNA segments, we assume the dsDNA has Ω̅ microstates (discretized by solid angle so that 
the length of the dsDNA segment does not affect this number). 
 
As shown in Fig. S4D, the second random walk must end in a spherical shell of radius 𝑙dsDNA 
surrounding the endpoint of the first random walk (note that we neglect the negligible width of 
the DNA double helix). We combine the two random walks into a single random walk with 2𝑛 
steps by reversing the direction of the second random walk (pink) and translating it by −𝑙dsDNA 
so that it starts where the first random walk (purple) ends. Hence, the diFab can bind bivalently 
if and only if this effective random walk ends at a distance 𝑙dsDNA from the origin.  
 
Since 𝑃(𝑟 ) is radially symmetric about the origin, the number of microstates for any particular 
orientation of the dsDNA will be Ω̅2𝑛𝑃(𝑙dsDNA)𝑑𝑉 and the total number of microstates 
considering all dsDNA orientations will be Ω̅2𝑛+1𝑃(𝑙dsDNA)𝑑𝑉. However, in preparation for case 
4 below, it is instructive to compute the probability over linker states as the average over all 
dsDNA orientations, 
𝑝(𝑙dsDNA, 𝑙ssDNA, 0) =
𝑑𝑉
4 𝜋  𝑙dsDNA
2 ∫ 𝑃(?⃑?) 𝑑
2?⃑?
𝑥∈𝐵(0,𝑙dsDNA)
= 𝑃(𝑙dsDNA)𝑑𝑉
= 𝑑𝑉 (
3
4 𝜋 𝑛 𝑏ssDNA
2 )
3
2
𝑒
− 
3 𝑙dsDNA
2
4 𝑛 𝑏ssDNA
2
, [S8]
 
where 𝐵(𝑧, 𝑟) represents the spherical shell of radius 𝑟 centered at 𝑧, 𝑃(?⃑?) is given by Eq. S5 
with 𝑛 → 2𝑛, and in the second step we used the radial symmetry of 𝑃(?⃑?). The number of 
microstates is now given by Ω̅2𝑛+1𝑝(𝑙dsDNA, 𝑙ssDNA, 0) where the prefactor represents the Ω̅
2𝑛 
orientations of the ssDNA and the Ω̅ orientations of the dsDNA. The similarity between Eqs. S7 
and S8 reflect the symmetry between the dsDNA and the linker length in the system. 
 
Case 4: 𝑙dsDNA ≠ 0⃗ , 𝑙linker ≠ 0⃗  
Finally, we turn to the case of a general diFab where the two ssDNA random walks are 
separated by a displacement 𝑙dsDNA of dsDNA and must end with displacement 𝑙linker from each 
other. As above, we transform these two random walks into a single effective random walk with 
2𝑛 steps that must finish in a spherical shell centered at 𝑙linker with radius 𝑙dsDNA (Fig. S4E). 
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Analogous to case 3 above, the fraction of states of the dsDNA and ssDNA linker that allow 
bivalent binding is given by 
𝑝(𝑙dsDNA, 𝑙ssDNA, 𝑙linker) =
𝑑𝑉
4 𝜋  𝑙dsDNA
2 ∫ 𝑃(?⃑?) 𝑑
2?⃑?
𝑥∈𝐵(𝑙linker ,𝑟)
[S9] 
where 𝐵(𝑧, 𝑟) represents the spherical shell of radius 𝑟 centered at 𝑧 and 𝑃(?⃑?) is given by Eq. S5 
with 𝑛 → 2𝑛. This final integral is straightforward to evaluated analytically (see the 
Supplementary Mathematica notebook), yielding  
𝑝(𝑙dsDNA, 𝑙ssDNA, 𝑙linker) =
𝑑𝑉
𝑙linker  𝑙dsDNA
√
3
16 𝜋3𝑛 𝑏ssDNA
2 𝑒
− 
3(𝑙linker
2 +𝑙dsDNA
2 )
4 𝑛 𝑏ssDNA
2
sinh(
3 𝑙linker  𝑙dsDNA
2 𝑛 𝑏ssDNA
2 ) . [S10] 
This leads to Eq. 6 with 𝑏ssDNA = 2𝜉ssDNA, 𝑛 =
𝑙ssDNA
2𝜉ssDNA
, and with the constant 𝑑𝑉 dropped (since 
it will be absorbed into ?̃?). Therefore, the number of configurations for the bivalently bound 
diFab linker is given by Ω2 = Ω̅
2𝑛+1𝑝(𝑙dsDNA, 𝑙ssDNA, 𝑙linker).  
 
Note that 𝑝(𝑙dsDNA, 𝑙ssDNA, 𝑙linker) has no free parameters and is dictated purely by the geometry 
of each diFab. Furthermore, the factor 𝑝(𝑙dsDNA, 𝑙ssDNA, 𝑙linker) is the only term that varies 
between diFabs, whereas all remaining parameters (e.g., 𝐾D
(1)
, 𝐸2 − 𝐸1) are the same across all 
constructs. Hence, it is the solely the loss of entropy contained in 𝑝(𝑙dsDNA, 𝑙ssDNA, 𝑙linker) that 
determines how much better one diFab will be than another. Lastly, we point out that Eq. S10 is 
symmetric upon interchanging 𝑙dsDNA and 𝑙linker, since every state of the ssDNA in a bivalently 
bound diFab with 𝑙dsDNA dsDNA and receptor binding sites spaced 𝑙linker apart would also 
enabled bivalent binding (with the locations of the dsDNA and the receptor interchanged) of a 
diFab with a length 𝑙linker of dsDNA binding to a receptor with binding sites spaced 𝑙dsDNA apart. 
 
The Number of Bivalent versus Monovalent Microstates for the Linker 
In this section, we compute the full expressions for the number of microstates Ω1 and Ω2 of the 
monovalently bound and bivalently-bound Env spike shown in Fig. S3A (including the flexibility 
𝑙flex), which will permit us to compute the relative probability of these two states using Eq. 2. We 
note that the number of microstates for the unbound state Ω0 need not be computed explicitly 
because the ratio of entropy and energy between the unbound and monovalently bound states 
are quantified by 𝐾D
(1)
 in Eq. 1. 
 
The number of microstates of the monovalently bound state is given by  
Ω1 = Ω̅
2𝑛+1, [S11] 
where, as above, Ω̅ denotes the microstates of each segment in the linker (the 2𝑛 ssDNA 
segments and the 1 dsDNA segment are all assumed to rotate freely in the ideal chain model). 
Note that this simple model neglects all interactions between the DNA, Fab, and Env including 
self-intersections. 
 
When 𝑙flex = 0, the multiplicity of the bivalently bound state was found above to be 
Ω̅2𝑛+1𝑝(𝑙dsDNA, 𝑙ssDNA, 𝑙linker) where 𝑙linker represents the distance spanned by the linker. 
Making the same approximation as in Appendix B that the direction of flexibility of the Fabs and 
the line joining the Fabs’ C-termini are colinear, the number of bivalent microstates is given by 
Ω2 =
Ω̅2𝑛+1
(Δ𝑙)2
∫ ∫ 𝑝(𝑙dsDNA, 𝑙ssDNA, 𝑙linker + 𝑥2 − 𝑥1)𝑑𝑥2𝑑𝑥1
𝑙flex
2
−
𝑙flex
2
𝑙flex
2
−
𝑙flex
2
≈
Ω̅2𝑛+1𝑙flex
2
(Δ𝑙)2
𝑝(𝑙dsDNA, 𝑙ssDNA, 𝑙linker). [S12]
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In the first equality, Δ𝑙 represents the a length scale to transform the flexibility imparted by the 
Fabs into a number of microstates as in Eq. 3 and Appendix B. In the second equality, we 
assumed 𝑙flex ≪ 𝑙linker (since 𝑙flex ≈ 20 nm and 𝑙linker ≈ 1 nm) so that 𝑙linker + 𝑥2 − 𝑥1 ≈ 𝑙linker in 
the integrand. Substituting Eqs. S10 and S12 into Eq. 2, the relative probability of the bivalent 
and monovalent states takes the form  
𝑝2
𝑝1
=
𝑒−𝛽(𝐸2−𝐸1)𝑑𝑉
(Δ𝑙)2
𝑙flex
2
𝑙linker  𝑙dsDNA
√
3
16 𝜋3𝑛 𝑏ssDNA
2 𝑒
− 
3(𝑙linker
2 +𝑙dsDNA
2 )
4 𝑛 𝑏ssDNA
2
sinh(
3 𝑙linker  𝑙dsDNA
2 𝑛 𝑏ssDNA
2 )
≡ ?̃?  ?̃?(𝑙dsDNA, 𝑙ssDNA) [S13]
 
where we have defined the prefactor ?̃? =
𝑒−𝛽(𝐸2−𝐸1)𝑑𝑉
(Δ𝑙)2
 containing the unknown constants that are 
independent of the diFab and Env and ?̃?(𝑙dsDNA, 𝑙ssDNA) to be the remaining geometry-
dependent terms as per Eq. 7. Using the normalization condition 𝑝0 + 𝑝1 + 𝑝2 = 1, we recover 
Eq. 8 for the % neutralization of HIV-1 for a diFab linked together by dsDNA and ssDNA. 
 
As a final aside, note that the small persistence length of the ssDNA (𝜉ssDNA = 0.1 nm ≈ 0.1 
bases) of the ssDNA implies that there are at least 𝑛 =
12 bases
0.1 bases
= 120 segments in each random 
walk. In this limit, the ideal chain model and worm-like chain model converge to the same result, 
and hence working with a more complicated polymer physics framework will not alter the result.   
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D. Model Parameters and Alternate Characterizations of the Data 
 
In this section, we consider the following three models: (i) The model used throughout the main 
text that includes the effect of ssDNA with a persistence length of 𝜉ssDNA = 0.1 nm ≈ 0.1 bases of 
free ssDNA, (ii) the model where ssDNA is included in the linker with the persistence length 
𝜉ssDNA = 1.5 nm = 2.3 bases of free ssDNA in solution, and (iii) the model where ssDNA is 
completely ignored within the linker. For each model, we list the best-fit parameter values and 
show how well the model compares to the experimental fits of the data. 
 
All fit parameters were inferred using NonlinearModelFit in Mathematica, where the (logarithms 
of the) model IC50 were fit to the experimentally measured values. Logarithms were used for 
fitting stability and to prevent the large IC50 values from disproportionately influencing the results. 
Rather than using the entire length titration data in Fig. 1C, fitting was done using the five diFab 
lengths d=50, 56, 60, 64, 68 around the optimal diFab length to ensure that the diFab length 
data does not dominate the fit results (see Supplementary Mathematica notebook where the 
fitting and plots are reproduced).  
 
In addition to the parameters shown, all models converted between length and base pairs of 
dsDNA using 𝑙dsDNA = 𝑑(0.34
nm
bp
) and for ssDNA using 𝑙ssDNA = 𝑠 (0.64
nm
base
). While the value 
𝑙linker = 21 nm was inferred through fitting, we note that this value could also have been 
determined without recourse to fitting by noting that the optimal diFab in Fig. 1C had a dsDNA 
length of d=62 corresponds to 21 nm. 
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Modeling diFab Linkers with a Reduced ssDNA Persistence Length (𝝃𝐬𝐬𝐃𝐍𝐀 = 𝟎. 𝟎𝟖 𝐧𝐦) 
The best fit parameters for this model are given in Table S1. The results of this model are 
shown in the main text (Fig. 2D, Fig. 3C, Fig. 4C, and Fig. 5C), and we will not reproduce them 
here.  
 
Description Parameter Value Method Obtained 
Dissociation constant of the 
first diFab arm binding to Env 
𝐾𝐷
(1)
 74 nM 
Fab neutralization 
data (not fit) 
Accounts for diFab flexibility 
from (i) Fab CH1-CL flexibility 
with respect to VH-VL domains, 
(ii) disorder within the CH1 C-
termini, and (iii) the Sulfo-
SMCC linker 
𝑙flex 1.8 nm Fit from data 
Distance between Fab CH1 
domain C-termini that must be 
spanned by the dsDNA+ssDNA 
linker for a bivalently-bound 
diFab 
𝑙linker 21 nm Fit from data 
Persistence length of ssDNA 
in diFab constructs 
𝜉ssDNA 0.1 nm Fit from data 
The energetic and entropic 
increase in relative probability 
of a bivalently- versus a 
monovalently-bound diFab 
(i.e., the avidity effect) 
?̃? ?̃?(𝑙dsDNA, 𝑙ssDNA) ?̃? = 5.2 × 10
5 
?̃? fit from data; 
?̃? was not fit but 
determined by the 
diFab composition 
as per Eqs. 6 and 7  
 
Table S1. Model parameters using ssDNA with the persistence length 𝝃𝐬𝐬𝐃𝐍𝐀 = 𝟎. 𝟎𝟖 𝐧𝐦.  
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Modeling diFab Linkers with the Persistence Length for Free ssDNA (𝝃𝐬𝐬𝐃𝐍𝐀 = 𝟏. 𝟓 𝐧𝐦) 
The simplest model of the diFab linker that includes both the dsDNA and ssDNA would 
characterize the dsDNA as a rigid rod and the ssDNA as an ideal chain with the persistence 
length of 𝜉ssDNA =2-6 bases determined for free ssDNA (43, 44).  
 
This model disagrees with the data in several ways: (i) The 12 bases ssDNA flanking the 
dsDNA in Fig. S5A are composed of a few long segments (with Kuhn length 2𝜉ssDNA = 4 bases) 
that can enable diFabs whose dsDNA is too short or too long to bivalently bind with a minimum 
entropic cost. Thus, the model predicts a broader IC50 profile than suggested by the data. (ii) 
Trading dsDNA for ssDNA in the rigidity constructs in Fig. S5B incurs a minimal cost in potency. 
For example, even though the measured IC50 value of (d=62, s=12) is about 100x smaller than 
that of (d=50, s=18), this model predicts less than a 2x difference between the two constructs 
since these twelve nucleotides only represent three additional segments as ssDNA (with a 
concomitant small increase in the entropic penalty of bivalently binding). (iii) Constructs with the 
same dsDNA length but different ssDNA lengths shown in Fig. S5C are predicted to behave 
nearly identically because the entropy cost of binding bivalently increases slowly with the 
number of ssDNA segments (and each segment is composed of 4 bases ssDNA). Parameter 
values for this model are given in Table S2. 
 
Fig. S5 demonstrates the lack of agreement between the data and a model of ssDNA using 
𝜉ssDNA = 1.5 nm = 2 bases (the model is worse for larger ssDNA persistence lengths). Together 
with the DLS data (Fig. 1D), these results suggest that the ssDNA in the diFab linkers is more 
compact than free ssDNA. 
 
Description Parameter Value Method Obtained 
Dissociation constant of the 
first diFab arm binding to Env 
𝐾𝐷
(1)
 74 nM 
Fab neutralization 
data (not fit) 
Accounts for diFab flexibility 
from (i) Fab CH1-CL flexibility 
with respect to VH-VL domains, 
(ii) disorder within the CH1 C-
termini, and (iii) the Sulfo-
SMCC linker 
𝑙flex 1.4 nm Fit from data 
Distance between Fab C-
termini that must be spanned 
by the dsDNA+ssDNA linker for 
a bivalently-bound diFab 
𝑙linker 21 nm 
Set to this value to 
slightly improve 
model results 
(see Mathematica 
notebook) 
Persistence length of ssDNA 
in the diFab 
𝜉ssDNA 1.5 nm 
From literature (43, 
44) 
The energetic and entropic 
increase in relative probability 
of a bivalently- versus a 
monovalently-bound diFab 
(i.e., the avidity effect) 
?̃? ?̃?(𝑙dsDNA, 𝑙ssDNA) 
?̃? = 5.1 × 105 
 
?̃? fit from data; 
?̃? was not fit but 
determined by the 
diFab composition 
as per Eqs. 6 and 7 
 
Table S2. Model parameters using ssDNA with the persistence length 𝝃𝐬𝐬𝐃𝐍𝐀 = 𝟏. 𝟓 𝐧𝐦.  
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Figure S5. Modeling the diFab linker with ssDNA included and characterized by its 
persistence length 𝝃𝐬𝐬𝐃𝐍𝐀 = 𝟏. 𝟓 𝐧𝐦 in solution. Predicted diFab behavior if the ssDNA in the 
linker has the same persistence length as free ssDNA in solution. Model results are shown for 
the analogous plots to (A) Fig. 2D, (B) Fig. 3C, (C) Fig. 4C, and (D) Fig. 5C. Parameter values 
are given in Table S2. 
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Modeling diFab Linkers with ssDNA Excluded 
Fig. S6 shows the model predictions using Eq. 4, which approximates the ssDNA in the linker as 
having zero length. Compared to the model we consider in the main text that assumes the 
ssDNA has a shortened persistence length, this model predicts a sharper length dependence 
(Fig. S6A) but still captures the general shape of the data. By construction, the extra long 
constructs (Fig. S6C) in this model depend solely on the length of their dsDNA, and hence the 
neutralization potencies of diFabs with the same length of dsDNA but different lengths of ssDNA 
are predicted to be the same.  
 
Note that in Fig. 2D, we showed this model with the slightly sub-optimal 𝑙flex = 1.8 nm to match 
the optimal 𝑙flex parameter of the second model that includes ssDNA (Table S1). In Fig. S6, we 
show the optimal model results when the ssDNA is excluded, with parameters given in Table S3. 
 
 
Description Parameter Value Method Obtained 
Dissociation constant of the 
first diFab arm binding to Env 
𝐾𝐷
(1)
 74 nM 
Fab neutralization 
data (not fit) 
Accounts for diFab flexibility 
from (i) Fab CH1-CL flexibility 
with respect to VH-VL domains, 
(ii) disorder within the CH1 C-
termini, and (iii) the Sulfo-
SMCC linker 
𝑙flex 2.6 nm Fit from data 
Distance between Fab CH1 C-
termini that must be spanned 
by the dsDNA linker for a 
bivalently-bound diFab 
𝑙linker 21 nm Fit from data 
The energetic and entropic 
increase in relative probability 
of a bivalently versus a 
monovalently bound diFab (i.e., 
the avidity effect) 
𝛼 𝑛(𝑙dsDNA, 𝑙ssDNA) 
𝛼 = 40 
 
𝛼 fit from data; 
𝑛 was not fit but 
determined by the 
diFab composition 
as per Eq. 3 
 
Table S3. Model parameters excluding the ssDNA in the linker.  
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Figure S6. Modeling the diFab linker with ssDNA excluded. When diFab behavior is 
determined solely by its dsDNA content, HIV-1 neutralization is given by Eq. 4. Model results 
are shown for the analogous plots to (A) Fig. 2D, (B) Fig. 3C, (C) Fig. 4C, and (D) Fig. 5C. 
Parameter values are given in Table S3. 
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E. diFab Potencies Against the HIV-1 Strain THRO4156 
 
To verify that the loss in diFab potency when dsDNA was exchanged for ssDNA (Fig. 3) was an 
inherent property of the linker and not a specific response to the Tier 1B HIV-1 strain 6535.3 
used in our neutralization assays, we compared the neutralization potencies of the rigidity 
diFabs against the Tier 1B HIV-1 6535.3 strain and the Tier 2 HIV-1 strain THRO4156. In both 
cases, there is a sharp decline in diFab potency when the dsDNA length decreases from d=62 
to d≤50. 
 
 
 
 
Figure S7. Comparison of Neutralization of Rigidity diFabs against two different HIV-1 
Strains. Rigidity diFabs were constructed to keep the length of DNA held constant while ssDNA 
bases were substituted for dsDNA. (A) Neutralization of the 3BNC60 rigidity diFabs (Fig. 3B) 
against the Tier 1B HIV-1 strain 6535.3, showing a steep decline in diFab efficacy when the 
dsDNA length was decreased below d=62 bp. (B) Neutralization of the same diFabs against the 
Tier 2 HIV-1 strain THRO4156 showing a similar sharp dependence on the dsDNA length. 
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F. Generalizing the Model to Gapped Fabs and TriFabs 
 
In this section, we discuss how the model of diFab neutralization (Eq. 8) can be generalized to 
account for either gapped Fabs with ssDNA breaks within the dsDNA segment (Fig. 5A) or 
triFabs that combine three Fabs to achieve greater avidity effects. 
 
Gapped Fabs represent a Random Walk of dsDNA 
Suppose the dsDNA portion of the linker is composed of 𝑛1 segments of 𝑑1 bp dsDNA and one 
segment of 𝑑2 bp dsDNA flanked by 𝑠 ssDNA on either side (the constructs in Fig. 5A are (𝑛1 =
2, 𝑑1 = 10, 𝑑2 = 10, 𝑠 = 17) and (𝑛1 = 2, 𝑑1 = 10, 𝑑2 = 22, 𝑠 = 17)). The rigidity and extra long 
constructs have 𝑛1 = 0 so that the single dsDNA segment 𝑑2 is flanked by two ssDNA segments 
of length 𝑠 that are treated as random walks. For the gapped Fabs, we will consider the two 
ssDNA segments as well as the 𝑛1 dsDNA segments of length 𝑑1 as random walks about the 
single dsDNA segment of length 𝑑2. In doing so, we assume that the 5 ssDNA bases 
interspersed between the dsDNA as free hinges with negligible lengths. 
 
Eq. S9 in Appendix C shows that in the case 𝑛1 = 0 where the linker must span the distance 
𝑙linker, the combined ssDNA random walk (2𝑛 segments of length 𝑏ssDNA) starting at the origin 
must end on a sphere of radius 𝑙dsDNA around 𝑙linker. When 𝑛1 > 0, the combined ssDNA 
random walk ends at the arbitrary point 𝑧, and the dsDNA random walk must then start at 𝑧 and 
end on a sphere of radius 𝑙𝑑2 = 𝑑2(0.34
nm
bp
) around 𝑙linker, representing the length of the 𝑑2 
segment. Using the probability density Eq. S5 for a random walk, the probability that the linker in 
a gapped Fab will bivalently bind is given by 
𝑝gap(𝑙dsDNA, 𝑙ssDNA, 𝑙linker) = ∫ ∫ 𝑃ssDNA(𝑧)𝑃dsDNA(?⃑? − 𝑧)𝑑
3𝑧
𝑧∈ℝ3
𝑑3?⃑?
𝑥∈𝐵(𝑙linker ,𝑙d2)
[S14] 
where  
𝑃ssDNA(𝑧) = (
3
2𝜋𝑏ssDNA
2 (2𝑛)
)
3
2
𝑒
−
3𝑧2
2𝑏ssDNA
2 (2𝑛) [S15] 
represents the probability that the endpoint of the ssDNA random walk starting at the origin will 
end at 𝑧,  
𝑃dsDNA(?⃑? − 𝑧) = (
3
2𝜋𝑙𝑑1
2 𝑛1
)
3
2
𝑒
−
3|𝑥−𝑧|2
2𝑙𝑑1
2 𝑛1 [S16] 
denotes the probability that the endpoint of the dsDNA random walk starting at 𝑧 will end at ?⃑?, 
and 𝑙𝑑1 = 𝑑1(0.34
nm
bp
). Replacing 𝑝 → 𝑝gap and Ω̅
2𝑛 → Ω̅2𝑛+𝑛1 in Eq. S12 yields the desired 
number of microstates for the bivalent configuration. 
 
Fig. S8 shows how the potency of the optimal (d=62, s=12) construct decreases as the dsDNA 
segment is broken up into 𝑛′ pieces of equal length (𝑛1 = 𝑛
′ − 1, 𝑑1 = 𝑑2 =
62
𝑛′
, 𝑠 = 12). Since 
the 𝑛′ segments of dsDNA will be much more confined when the diFab is bivalently bound 
relative to the monovalent configuration, the entropic penalty of bivalent binding quickly 
increases with the number of segments leading to lower potency. 
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Figure S8. Potency of a gapped diFab made up of 62 bp dsDNA broken into 𝒏′ equal 
length pieces. Breaking up the dsDNA increases the entropic cost of bivalent binding, 
decreasing its potency.  
 
 
triFabs exhibit Greater Avidity than diFabs 
Since the two binding arms in the optimal diFab can decrease its IC50 by over 100x compared to 
the one-armed Fab (21), it is tempting to ask whether a construct with additional Fabs could 
further reduce the IC50. Here, we outline how our model can be extended to consider the a 
linear triFab consisting of three Fabs linked in a linear fashion via 62 bp dsDNA segments. The 
model predicts that optimal triFab will be 100x more potent than the optimal diFab, providing a 
method to leverage the knowledge of the HIV-1 Envelope spike we derived from our synthetic 
diFabs to engineer even more potent reagents.  
 
As in Eq. 9 (the model that considerers both the dsDNA and ssDNA in the linker), we neglect 
both the self-intersection of the linker as well as the intersection between the linker and the Env 
spike, though we note that these effects may be more prominent in a triFab than in a diFab. 
Furthermore, we neglect the combinatorics characterizing which binding arm attaches to an Env 
binding site (e.g., there are (
3
1
) ways to bind monovalently; (
3
2
) ways to bind bivalently, although 
simultaneously binding nearest neighbor arms will be different from binding the two arms 
furthest apart; and (
3
3
) ways to bind trivalently) as well as the details of these configurations 
(e.g., there are six possible configurations of binding the three triFab arms to the three Env 
epitopes). 
 
With these assumptions, the Boltzmann statistical weights for the triFab (analogous to those in 
Fig. 2B for the diFab) are 1, 
[Ab]
𝐾D
(1), 
[Ab]
𝐾D
(1) ?̃? ?̃?(𝑙dsDNA, 𝑙ssDNA), and 
[Ab]
𝐾D
(1) ?̃?
2 ?̃?(𝑙dsDNA, 𝑙ssDNA)
2 for the 
states with 0, 1, 2, and 3 Fab arms bound, respectively. Analogous to Eqs. 8 and 9, the 
probability of binding (and hence neutralizing) a spike is given by 
𝑝1 + 𝑝2 + 𝑝3 =
[Ab]
𝐾D
(1) +
[Ab]
𝐾D
(1) ?̃? ?̃?(𝑙dsDNA, 𝑙ssDNA) +
[Ab]
𝐾D
(1) ?̃?
2 ?̃?(𝑙dsDNA, 𝑙ssDNA)
2
1 +
[Ab]
𝐾D
(1) +
[Ab]
𝐾D
(1) ?̃? ?̃?(𝑙dsDNA, 𝑙ssDNA) +
[Ab]
𝐾D
(1) ?̃?
2 ?̃?(𝑙dsDNA, 𝑙ssDNA)2
[S17] 
with an IC50 given by 
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IC50
triFab =
𝐾D
(1)
1 + ?̃? ?̃?(𝑙dsDNA, 𝑙ssDNA) + ?̃?2 ?̃?(𝑙dsDNA, 𝑙ssDNA)2
. [S18] 
Substituting in the dsDNA length 𝑙dsDNA = (62 bp)(0.34
nm
bp
) from the optimal diFab and 
assuming that ssDNA strands of lengths 𝑙ssDNA = (12 bp)(0.64
nm
bp
) connect the Fabs and the 
dsDNA, we predict that the triFab should be able to achieve an IC50
triFab = 0.008 nM, 
representing a 100x improvement over the optimal IC50
diFab = 0.8 nM.  
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G. Bridge and Linker Sequences for diFabs 
 
Table S4 shows the bridge and linker sequences spanning the two diFab arms in the new 
constructs created in this work. Sequences were chosen to lack secondary structure and 
maintain thermal stability (see Methods). 
 
Construct dsDNA (d) ssDNA (s) DNA Sequence 
Rigidity 
(Fig. 3) 
58 14 
5- 
/5AmMC6/TTTTTTTTTTTTCTTTGTTCTTATTCTCTGCTTTTTCTTTCTTTCC
TCCTTCTCCCTCTTCTTCCCTTCTTC -3 
5- 
/5AmMC6/AAGAGAGAGAAAAGGAAGAAGGGAAGAAGAGGGAGAAGGAG
GAAAGAAAGAAAAAGCAGAGAATAAGAACAA -3 
 50 18 
5- 
/5AmMC6/TTTTTTTTTTTTCTTTGTTCTTATTCTCTGCTTTTTCTTTCTTTCC
TCCTTCTCCCTCTTCTTCCCTT -3 
5- 
/5AmMC6/AAGAGAGAGAAAAGGAAGAAGGGAAGAAGAGGGAGAAGGAG
GAAAGAAAGAAAAAGCAGAGAATAAGA -3 
 40 23 
5- 
/5AmMC6/TTTTTTTTTTTTCTTTGTTCTTATTCTCTGCTTTTTCTTTCTTTCC
TCCTTCTCCCTCTTCTT -3 
5- 
/5AmMC6/AAGAGAGAGAAAAGGAAGAAGGGAAGAAGAGGGAGAAGGAG
GAAAGAAAGAAAAAGCAGAGAA -3 
 30 28 
5- 
/5AmMC6/TTTTTTTTTTTTCTTTGTTCTTATTCTCTGCTTTTTCTTTCTTTCC
TCCTTCTCCCTC -3 
5- 
/5AmMC6/AAGAGAGAGAAAAGGAAGAAGGGAAGAAGAGGGAGAAGGAG
GAAAGAAAGAAAAAGCA -3 
 20 33 
5- 
/5AmMC6/TTTTTTTTTTTTCTTTGTTCTTATTCTCTGCTTTTTCTTTCTTTCC
TCCTTCT -3 
5- 
/5AmMC6/AAGAGAGAGAAAAGGAAGAAGGGAAGAAGAGGGAGAAGGAG
GAAAGAAAGAAA -3 
Extra-
long 
(Fig. 4) 
62 17 
5- /5AmMC6/TTTTTTTTTTTTTTTTTCTTTGTTCTTATTCTCTGCT -3 
5- /5Phos/TTTTCTTTCTTTCCTCCTTCTCCCTCTTCTTCCCTTCTTCCT -3 
5- /5Phos/GAGAAGGAGGAAAGAAAGAAAAAGCAGAGAATAAGAACAAAG 
-3 
5- /5AmMC6/AAGAGAAGAGAGAGAAAAGGAAGAAGGGAAGAAGAGG -3 
 62 42 
5- 
/5AmMC6/TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTCTTTGT
TCTTATTCTCTGCT -3 
5- /5Phos/TTTTCTTTCTTTCCTCCTTCTCCCTCTTCTTCCCTTCTTCCT -3 
5- 
/5Phos/GAGAAGGAGGAAAGAAAGAAAAAGCAGAGAATAAGAACAAAG-3 
5-
/5AmMC6/AAGAGAGAGAAAGAGAGAGAAAGAGAGAGAAAGAGAGAGAA
AAGGAAGAAGGGAAGAAGAGG -3 
 50 22 
5- /5AmMC6/TTTTTTTTTTTTTTTTTCTTTGTTCTTATTCTCTGCT -3 
5- /5Phos/TTCTTTCTTTCCTCCTTCTCCCTCTTCTTCCCTTC -3 
5- /5Phos/GAGAAGGAGGAAAGAAAGAAAGCAGAGAATAAGAA -3 
5- /5AmMC6/AAGAGAAGAGAGAGAAAAGGAAGAAGGGAAGAAGAGG -3 
 50 62 
5- 
/5AmMC6/TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTCTTTGT
TCTTATTCTCTGCT -3 
5- /5Phos/TTCTTTCTTTCCTCCTTCTCCCTCTTCTTCCCTTC -3 
5- /5Phos/GAGAAGGAGGAAAGAAAGAAAGCAGAGAATAAGAA -3 
51 
 
5- 
/5AmMC6/AAGAGAGAGAAAGAGAGAGAAAGAGAGAGAAAGAGAGAGAA
AAGGAAGAAGGGAAGAAGAGG -3 
Gapped 
(Fig. 5) 
5105105105 17 
5- /5AmMC6/TTTTTTTTTTTTCTTTGTTCTTATTCT -3 
5- /5Phos/TTTCTTCTCCCTCTTCTTCCCTTCT -3 
5- /5Phos/GGAGAAGAAAAGCAGAGAATAAGAA -3 
5- /5AmMC6/AAGAGAGAGAAAAAGGAAGAAGGGAAG -3 
 5105225105 17 
5- /5AmMC6/TTTTTTTTTTTTCTTTGTTCTTATTCT -3 
5- /5Phos/TTTCTTTCTTTCCTCCTTCTCCCTCTTCTTCCCTTCT -3 
5- /5Phos/GGAGAAGGAGGAAAGAAAGAAAAGCAGAGAATAAGAA -3 
5- /5AmMC6/AAGAGAGAGAAAAAGGAAGAAGGGAAG -3 
 
Table S4. Linker sequences In the diFab constructs.  
  
